Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other Non-Current Assets (2021 - 2022)

Bioventus (BVS) has disclosed Other Non-Current Assets for 2 consecutive years, with $2.8 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Other Non-Current Assets fell 94.45% year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Dec 2022, down 94.45%, and an annual FY2022 reading of $2.8 million, down 94.45% over the prior year.
  • Other Non-Current Assets was $2.8 million for Q4 2022 at Bioventus, down from $50.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $50.0 million in Q4 2021 and bottomed at $2.8 million in Q4 2022.